Clinical Pharmacology & Therapeutics · 1997 · 87 citations · 14 references
Fluconazole significantly increases the steady-state AUC of losartan and inhibits the formation of the active metabolite of losartan, E-3174. In contrast, fluconazole administration has no effect on the steady-state pharmacokinetics of eprosartan.
14
Wolfgang Wienen, Norbert Hauel, J. C. A. van Meel et al. · British Journal of Pharmacology · 1993 · 192 citations · Full text
Hypertension, Pharmacological Characterization, Cardiovascular Pharmacology +19
Alain Munafo, Yves Christen, Jürg Nussberger et al. · Clinical Pharmacology & Therapeutics · 1992 · 180 citations